- Topic
- Product safety
- Regulator
- FDA
- Published
- 2 November 2026
- For
- Imports
- Where it applies
- United States
From the notice
The Food and Drug Administration (FDA or we) proposes to amend the regulations on nutrient specifications and labeling for infant formula as part of its phased, comprehensive review of infant formula nutrients. This action, if finalized, would amend the minimum and/or maximum levels of four required nutrients, change the unit of measure for certain nutrients, change the permitted source to meet one of the nutrient requirements, and amend the content of the required labeling. This action alsoThe full text is at the source
Olive tells you which of these hit your products.
Olive reads every change like these against your own products, codes and trade lanes, whether you import, export or both, and drafts the update to your compliance program for your approval. Nothing changes without you.
Olivra lists official notices for information only. It is not legal advice, and Olive is not a lawyer or a licensed customs broker. The official text at the source is what counts.
More from FDA
- Safety
Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination
FDAUnited StatesImports - Safety
Essential Drug Delivery Performance Characteristics for Devices Intended To Deliver Drugs and
FDAUnited StatesImports - Safety
Medical Devices; Anesthesiology Devices; Classification of the Over-the-Counter Device To Assess
FDAUnited StatesImports - Safety
Medical Devices; Anesthesiology Devices; Classification of the Spinal Imaging System for
FDAUnited StatesImports